Antibiotic Resistant Strains (other than Glycopeptide) |
|
|
NRS1
|
Mu50; ATCC 700699 |
Staphylococcus aureus |
Resistant to aminoglycosides and tetracycline (minocycline) |
|
|
NRS70
|
N315 |
Staphylococcus aureus |
Resistant to erythromycin |
|
|
NRS100
|
COL |
Staphylococcus aureus |
Resistant to oxacillin and tetracycline |
|
|
NRS106
|
RN4220/pG01 |
Staphylococcus aureus |
pG01 encodes resistance to gentamicin, trimethoprim, and quarternary ammonium compounds |
|
|
NRS107
|
RN4220/pG0400 |
Staphylococcus aureus |
pG0400 encodes mupirocin resistance |
|
|
NRS108
|
A960649 |
Staphylococcus aureus |
Resistance to gentamicin |
|
|
NRS119
|
SA LinR #12 |
Staphylococcus aureus |
Resistant to linezolid; identical to NRS120 and closely related to NRS121 by PFGE
|
|
|
NRS120
|
SA LinR #13 |
Staphylococcus aureus |
Resistant to linezolid; identical to NRS119 and closely related to NRS121 by PFGE |
|
|
NRS121
|
SA LinR #14 |
Staphylococcus aureus |
Resistant to linezolid; closely related to NRS119 and NRS120 by PFGE |
|
|
NRS127
|
N/A |
Staphylococcus aureus |
Nonsusceptible to Linezolid |
|
|
NRS128
|
NCTC8325 (RN0031) |
Staphylococcus aureus |
pI258 is a 28 kb penicillinase pladsmid of incompatibility group I, encoding resistance to Hg, Cd, Pb, AsO4=, AsO3=, as well as to penicillin and erythromycin. Carries Tn551. |
|
|
NRS129
|
NCTC8325 (RN0153) |
Staphylococcus aureus |
pC221 is a 4.5kb rolling circle plasmid of the pT181 family. It encodes chloramphenicol resistance plus a relaxation complex enabling its conjugative. |
|
|
NRS130
|
NCTC8325 (RN2442) |
Staphylococcus aureus |
pE194 is a 3.8 kb rolling circle plasmid encoding inducible erythromycin resistance. |
|
|
NRS131
|
NCTC8325 (RN2887) |
Staphylococcus aureus |
pC194 is a 3.2 kb rolling circle plasmid encoding inducible chloramphenicol transacetylase and is the basis for many cloning vectors. |
|
|
NRS269
|
GC 7647 |
Staphylococcus aureus |
Staphylococccus aureus strain resistant to the glycylcycline, tigecycline (GAR-936). |
|
|
NRS271
|
N/A |
Staphylococcus aureus |
Linezolid-resistant, containing phage type E-MRSA 15 |
|
|
|
Genome Sequenced Strains |
|
|
NRS1
|
Mu50; ATCC 700699 |
Staphylococcus aureus |
Vancomycin-intermediate strain isolated in 1996; whole genome sequenced at Juntendo University, Japan |
|
|
NRS70
|
N315 |
Staphylococcus aureus |
Methicillin-resistant strain isolated in 1982; whole genome sequenced at the National Institute of Technology and Evaluation, Tokyo. |
|
|
NRS71
|
Sanger 252 |
Staphylococcus aureus |
Epidemic MRSA strain sequenced at Sanger Centre, UK |
|
|
NRS72
|
Sanger 476 |
Staphylococcus aureus |
Hyper-virulent community-acquired MSSA sequenced at Sanger Centre, UK |
|
|
NRS77
|
NCTC 8325; RN1 |
Staphylococcus aureus |
Strain sequenced at Univ. of Oklahoma
|
|
|
NRS100
|
COL |
Staphylococcus aureus |
Strain sequenced at TIGR |
|
|
NRS101
|
RP62A; ATCC 35984 |
Staphylococcus epidermidis |
Slime positive strain sequenced by TIGR |
|
|
NRS123
|
MW2;C1999000459;USA400;99065 |
Staphylococcus aureus |
A community-acquired MRSA strain sequenced at the National Institute of Technology and Evaluation, Tokyo. |
|
|
|
Glycopeptide Intermediate Staphylococci |
|
| |
|
|
|
|
|
|
|
NRS1
|
Mu50; ATCC 700699 |
Staphylococcus aureus |
= 8 |
= 8 |
Wound |
Japan |
|
|
NRS2
|
Mu3; ATCC 700698 |
Staphylococcus aureus |
= .5 |
= 2 |
Purulent sputum |
Japan |
|
|
NRS3
|
HIP5827 |
Staphylococcus aureus |
= 4 |
= 8 |
Peritoneal fluid |
Michigan (United States) |
|
|
NRS4
|
HIP5836 |
Staphylococcus aureus |
= 4 |
= 4 |
Bloodstream |
New Jersey (United States) |
|
|
NRS6
|
HIP04645 |
Staphylococcus epidermidis |
= 4 |
= 4 |
Bloodstream |
Wisconsin (United States) |
|
|
NRS7
|
N/A |
Staphylococcus epidermidis |
= 8 |
= 8 |
Other |
California (United States) |
|
|
NRS8
|
HIP4680 |
Staphylococcus epidermidis |
= 8 |
= 8 |
Bloodstream |
Virginia (United States) |
|
|
NRS9
|
HIP05979 |
Staphylococcus haemolyticus |
= 4 |
= 8 |
Peritoneal fluid |
New York (United States) |
|
|
NRS11
|
SA MER |
Staphylococcus aureus |
= 2 |
= 2 |
Other |
France |
|
|
NRS12
|
SA MER-S6 |
Staphylococcus aureus |
= 8 |
= 8 |
Other |
France |
|
|
NRS13
|
SA MER-S12 |
Staphylococcus aureus |
= 4 |
= 4 |
Other |
France |
|
|
NRS14
|
SA MER-S20 |
Staphylococcus aureus |
= 8 |
= 8 |
Other |
France |
|
|
NRS17
|
HIP06297; 98-489 smw |
Staphylococcus aureus |
= 8 |
= 8 |
Bloodstream |
New York (United States) |
|
|
NRS18
|
HIP06854 |
Staphylococcus aureus |
= 4 |
= 4 |
Wound |
New Jersey (United States) |
|
|
NRS19
|
HIP07256 |
Staphylococcus aureus |
= 2 |
= 4 |
Bloodstream |
Illinois (United States) |
|
|
NRS21
|
HIP07920 |
Staphylococcus aureus |
= 4 |
= 4 |
Bloodstream |
Rhode Island (United States) |
|
|
NRS22
|
HIP07930; USA600;99758 |
Staphylococcus aureus |
= 4 |
= 4 |
Bloodstream |
New York (United States) |
|
|
NRS23
|
HIP08926 |
Staphylococcus aureus |
= 4 |
= 4 |
Bone/joint |
California (United States) |
|
|
NRS24
|
HIP09143 |
Staphylococcus aureus |
= 4 |
= 4 |
Wound |
Ohio (United States) |
|
|
NRS26
|
HIP09313 |
Staphylococcus aureus |
= 2 |
= 4 |
Bloodstream |
Texas (United States) |
|
|
NRS27
|
HIP09433 |
Staphylococcus aureus |
= 4 |
= 4 |
Other |
Michigan (United States) |
|
|
NRS28
|
HIP09662 |
Staphylococcus aureus |
= 2 |
= 4 |
Peritoneal fluid |
West Virginia (United States) |
|
|
NRS29
|
HIP09735 |
Staphylococcus aureus |
= 2 |
= 4 |
Bloodstream |
North Carolina (United States) |
|
|
NRS34
|
N/A |
Staphylococcus epidermidis |
= 4 |
= 4 |
Other |
California (United States) |
|
|
NRS35
|
LIM 1 |
Staphylococcus aureus |
= 2 |
= 2 |
Bloodstream |
France |
|
|
NRS36
|
LIM 2 |
Staphylococcus aureus |
= 2 |
= 4 |
Bloodstream |
France |
|
|
NRS37
|
LIM 3 |
Staphylococcus aureus |
= 2 |
= 4 |
Device/foreign object |
France |
|
|
NRS39
|
99.3795.V |
Staphylococcus aureus |
= 4 |
= 4 |
Other |
Scotland |
|
|
NRS49
|
N/A |
Staphylococcus aureus |
= 4 |
= 4 |
Bloodstream |
South Korea |
|
|
NRS50
|
N/A |
Staphylococcus haemolyticus |
= 4 |
= 4 |
Wound |
Texas (United States) |
|
|
NRS51
|
HIP09740 |
Staphylococcus aureus |
= 4 |
= 4 |
Other |
California (United States) |
|
|
NRS52
|
HIP09737 |
Staphylococcus aureus |
= 4 |
= 4 |
Other |
California (United States) |
|
|
NRS53
|
N/A |
Staphylococcus epidermidis |
= 4 |
= 4 |
Peritoneal fluid |
Pennsylvania (United States) |
|
|
NRS54
|
BR 15 |
Staphylococcus aureus |
= 4 |
= 4 |
Wound |
Brazil |
|
|
NRS56
|
BR 5 |
Staphylococcus aureus |
= 8 |
= 8 |
Wound |
Brazil |
|
|
NRS60
|
N/A |
Staphylococcus epidermidis |
= 8 |
= 4 |
Bloodstream |
Oregon (United States) |
|
|
NRS62
|
N/A |
Staphylococcus haemolyticus |
= 4 |
= 4 |
Other |
Texas (United States) |
|
|
NRS63
|
LY-1999 0620-01 |
Staphylococcus aureus |
= 8 |
= 4 |
Bloodstream |
Oman |
|
|
NRS64
|
LY-1999 0620-02 |
Staphylococcus aureus |
= 2 |
= 2 |
Bloodstream |
Oman |
|
|
NRS65
|
LY-1999 0620-03 |
Staphylococcus aureus |
= 4 |
= 8 |
Bloodstream |
Oman |
|
|
NRS68
|
N/A |
Staphylococcus aureus |
= 4 |
= 2 |
Bloodstream |
Kentucky (United States) |
|
|
NRS69
|
Shae 2 |
Staphylococcus haemolyticus |
= 4 |
= 4 |
Bloodstream |
Kentucky (United States) |
|
|
NRS73
|
HIP10540 |
Staphylococcus aureus |
= 4 |
= 8 |
Wound |
Ohio (United States) |
|
|
NRS74
|
HIP10267 |
Staphylococcus aureus |
= 8 |
= 8 |
Bloodstream |
Maryland (United States) |
|
|
NRS76
|
C2000001227 |
Staphylococcus aureus |
= 4 |
= 4 |
Bloodstream |
Minnesota (United States) |
|
|
NRS79
|
IL |
Staphylococcus aureus |
= 2 |
= 4 |
Bloodstream |
Illinois (United States) |
|
|
NRS115
|
N/A |
Staphylococcus haemolyticus |
= 2 |
= 4 |
Wound |
California (United States) |
|
|
NRS116
|
N/A |
Staphylococcus haemolyticus |
= 2 |
= 4 |
Wound |
California (United States) |
|
|
NRS118
|
N/A |
Staphylococcus aureus |
= 8 |
= 8 |
Respiratory |
California (United States) |
|
|
NRS122
|
N/A |
Staphylococcus epidermidis |
= 4 |
= 4 |
Bloodstream |
Maryland (United States) |
|
|
NRS126
|
N/A |
Staphylococcus aureus |
= 4 |
= 4 |
Bloodstream |
Massachusetts (United States) |
|
|
NRS272
|
P1V44 |
Staphylococcus aureus |
= 4 |
= 4 |
Respiratory |
Belgium |
|
|
NRS283
|
160013 |
Staphylococcus aureus |
= 4 |
= 4 |
Bloodstream |
United Kingdom |
|
|
NRS402
|
HIP12864 |
Staphylococcus aureus |
|
= 8 |
Bloodstream |
Oklahoma (United States) |
|
|
NRS403
|
HIP13057 |
Staphylococcus aureus |
|
= 8 |
Bloodstream |
Michigan (United States) |
|
|
NRS404
|
HIP13036 |
Staphylococcus aureus |
|
= 8 |
Bloodstream |
Connecticut (United States) |
|
|
|
Glycopeptide Resistant Staphylococci |
|
| |
|
|
|
|
|
|
|
VRS1
|
HIP11714 |
Staphylococcus aureus |
> 256 |
> 32 |
Other |
Michigan (United States) |
|
|
VRS2
|
HIP11983 |
Staphylococcus aureus |
= 64 |
> 32 |
Wound |
Pennsylvania (United States) |
|
|
VRS3a
|
HIP13170 |
Staphylococcus aureus |
> 32 |
> 128 |
Other |
New York (United States) |
|
|
VRS3b
|
HIP13419 |
Staphylococcus aureus |
> 32 |
> 128 |
Other |
New York (United States) |
|
|
VRS4
|
HIP14300 |
Staphylococcus aureus |
|
> 128 |
Wound |
Michigan (United States) |
|
|
VRS5
|
HIP15178 |
Staphylococcus aureus |
|
> 32 |
Wound |
Michigan (United States) |
|
|
VRS6
|
AIS2006032 |
Staphylococcus aureus |
|
> 32 |
Wound |
Michigan (United States) |
|
|
VRS7
|
AIS2006045 |
Staphylococcus aureus |
> 64 |
|
Wound |
Michigan (United States) |
|
|
VRS8
|
71080 |
Staphylococcus aureus |
> 256 |
|
Other |
Michigan (United States) |
|
|
VRS9
|
AIS 080003 |
Staphylococcus aureus |
> 256 |
|
Wound |
Michigan (United States) |
|
|
VRS10
|
AIS 1000505 |
Staphylococcus aureus |
> 256 |
|
Wound |
Michigan (United States) |
|
|
VRS11a
|
AIS 1001095 |
Staphylococcus aureus |
> 256 |
|
Other |
Delaware (United States) |
|
|
VRS11b
|
AID1001123 |
Staphylococcus aureus |
> 256 |
|
Other |
Delaware (United States) |
|
|
|
Historical Strains |
|
|
NRS104
|
Cowan I; ATCC12598;NCTC8530 |
Staphylococcus aureus |
Isolated by Cowan septic arthritis in 1935; Serotype 1. |
|
|
NRS196
|
No. 49 |
Staphylococcus aureus |
Used by Dr. Glencross in research on phage 80 |
|
|
NRS198
|
No. 56 |
Staphylococcus aureus |
Strain was in existence as early as 1949. |
|
|
NRS199
|
No. 66; CN49I-Staph:I33 |
Staphylococcus aureus |
Strain was in existence as early as 1947. |
|
|
NRS201
|
No. 150; 12907 |
Staphylococcus aureus |
Strain was in existence as early as 1950. |
|
|
NRS202
|
No. 152; 16434 |
Staphylococcus aureus |
Strain was in existence as early as 1950. |
|
|
NRS203
|
No. 153; 13111 |
Staphylococcus aureus |
Strain was in existence as early as 1950. |
|
|
NRS204
|
No. 167; NCTC6571 |
Staphylococcus aureus |
Strain was in existence as early as 1940. Used in the original work of Lord Florey and colleagues in their work on Penicillin. Later acquired by NCTC from Sir Alexander Fleming and given number NCTC6571. |
|
|
NRS205
|
No. 208 |
Staphylococcus aureus |
One of the original penicillin-treated cases |
|
|
NRS207
|
No. 229 |
Staphylococcus aureus |
The Clevedon Code G strain |
|
|
NRS209
|
No. 315; 28243 |
Staphylococcus aureus |
Isolated in 1971; resistant to penicillin, ampicillin, and methicillin |
|
|
NRS210
|
No. 326; KCM 187 |
Staphylococcus aureus |
Strain was in existence as early as 1968. |
|
|
NRS211
|
No. 333 |
Staphylococcus aureus |
Strain was in existence as early as 1956; Dr. Gladstone's penicillinase producer |
|
|
NRS212
|
No. 344; 2748 |
Staphylococcus aureus |
Strain was in existence as early as 1957. |
|
|
NRS213
|
No. 348; 605E; G2 |
Staphylococcus aureus |
Strain was in existence as early as 1958. |
|
|
NRS214
|
No. 359 |
Staphylococcus aureus |
Strain was in existence as early as 1960. |
|
|
NRS215
|
No. 425; 5441 |
Staphylococcus aureus |
Strain was in existence as early as 1968. |
|
|
NRS216
|
No. 426; 5442 |
Staphylococcus aureus |
Strain was in existence as early as 1968; isolated from a burn case. |
|
|
NRS217
|
No. 430; 5446 |
Staphylococcus aureus |
Strain was in existence as early as 1968; from a case of osteomyelitis |
|
|
NRS218
|
No. 437; 96 |
Staphylococcus aureus |
Strain was in existence as early as 1968. |
|
|
NRS219
|
No. 536; NCTC9789; PS80 |
Staphylococcus aureus |
Strain was in existence as early as 1974; auxotrophic mutant phe-, leu-, ileu-, met- |
|
|
NRS220
|
No. 611; 46 |
Staphylococcus aureus |
Protein A producer |
|
|
NRS222
|
ATCC9144;NCTC6571;NCIB6571;NRRL B-314;No.750 |
Staphylococcus aureus |
Penicillin-sensitive strain; strain was in existence as early as 1978. |
|
|
NRS223
|
No. 784 |
Staphylococcus aureus |
Penicillin-resistant variant of strain KCM 187 (NRS210) |
|
|
NRS224
|
No. 690; NAG9 |
Staphylococcus aureus |
A mutant of 209P; lacks glucosamine synthetase. In existence as early as 1977. |
|
|
NRS225
|
No. 691 |
Staphylococcus aureus |
Penicillin tolerant strain. |
|
|
NRS274
|
No. 55-1 |
Staphylococcus aureus |
Penicillin resistant at 200 units/ml |
|
|
NRS275
|
No. 55-2 |
Staphylococcus aureus |
Penicillin resistant at 200 units/ml |
|
|
|
Known Clinically Associated Strains - ABCs' Collection from CDC |
|
|
NRS642
|
CA-126 |
Staphylococcus aureus |
PFGE USA100, PVL (-), TSST (-), SCCMEC II |
|
|
NRS643
|
CA-127 |
Staphylococcus aureus |
PFGE USA300, PVL (+), TSST (-), SCCMEC IV |
|
|
NRS644
|
CA-142 |
Staphylococcus aureus |
PFGE USA100, PVL (-), TSST(-) SCCMEC II |
|
|
NRS645
|
CA-224 |
Staphylococcus aureus |
PFGE IBERIAN, PVL (-), TSST (-), SCCMEC IV |
|
|
NRS646
|
CA-248 |
Staphylococcus aureus |
PFGE USA100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS647
|
CA-263 |
Staphylococcus aureus |
PFGE USA300, PVL (-),TSST(-), SCCMEC IV |
|
|
NRS648
|
CA-347 |
Staphylococcus aureus |
PFGE USA 600,PVL (-),TSST(-), SCCMEC II |
|
|
NRS649
|
CA-374 |
Staphylococcus aureus |
PFGE USA100,PVL (-),TSST(-), SCCMEC II |
|
|
NRS650
|
CA-401 |
Staphylococcus aureus |
PFGE USA100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS651
|
CA-409 |
Staphylococcus aureus |
PFGE USA200, PVL(-), TSST(+), SCCMEC II |
|
|
NRS652
|
CA-46 |
Staphylococcus aureus |
PFGE USA 1000, PVL(-), TSST(-), SCCMEC IV |
|
|
NRS653
|
CA-513 |
Staphylococcus aureus |
PFGE USA800, PVL(-),TSST(-), SCCMEC IV |
|
|
NRS654
|
CA-548 |
Staphylococcus aureus |
PFGE USA300, PVL(-), TSST(-), SCCMEC IV |
|
|
NRS655
|
CA-573 |
Staphylococcus aureus |
PFGE USA300, PVL (+), TSST (-), SCCMECIV |
|
|
NRS656
|
CA-576 |
Staphylococcus aureus |
PFGE USA100, PVL (-), TSST (-), SCCMEC II |
|
|
NRS657
|
CA-632 |
Staphylococcus aureus |
PFGE USA300, PVL(+), TSST(-), SCCMEC IV |
|
|
NRS658
|
CA-655 |
Staphylococcus aureus |
PFGE USA100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS659
|
CA-78 |
Staphylococcus aureus |
PFGE USA300, PVL(+), TSST(-), SCCMEC IV |
|
|
NRS660
|
CO-17 |
Staphylococcus aureus |
PFGE USA100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS661
|
CO-23 |
Staphylococcus aureus |
PFGE USA100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS662
|
CO-34 |
Staphylococcus aureus |
PFGE USA300, PVL(+), TSST(-), SCCMEC IV |
|
|
NRS663
|
CO-48 |
Staphylococcus aureus |
PFGE USA100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS664
|
CO-49 |
Staphylococcus aureus |
PFGE USA100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS665
|
CO-61 |
Staphylococcus aureus |
PFGE USA100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS666
|
CO-65 |
Staphylococcus aureus |
PFGE USA100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS667
|
CO-71 |
Staphylococcus aureus |
PFGE USA300, PVL(+), TSST(-), SCCMEC IV |
|
|
NRS668
|
CO-72 |
Staphylococcus aureus |
PFGE USA800, PVL(-), TSST(-), SCCMEC IV |
|
|
NRS669
|
CO-84 |
Staphylococcus aureus |
PFGE USA100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS670
|
CT-110 |
Staphylococcus aureus |
PFGE USA100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS671
|
CT-138 |
Staphylococcus aureus |
PFGE USA100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS672
|
CT-142 |
Staphylococcus aureus |
PFGE USA100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS673
|
CT-174 |
Staphylococcus aureus |
PFGE USA100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS674
|
CT-178 |
Staphylococcus aureus |
PFGE USA100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS675
|
CT-189 |
Staphylococcus aureus |
PFGE USA800, PVL(-), TSST(-), SCCMEC IV |
|
|
NRS676
|
CT-19 |
Staphylococcus aureus |
PFGE USA1000, PVL(+), TSST(-), SCCMEC IV |
|
|
NRS677
|
CT-228 |
Staphylococcus aureus |
PFGE USA300, PVL(+), TSST(-), SCCMEC IV |
|
|
NRS678
|
CT-58 |
Staphylococcus aureus |
PFGE USA500, PVL(-), TSST(-), SCCMEC IV |
|
|
NRS679
|
CT-98 |
Staphylococcus aureus |
PFGE USA100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS680
|
GA-198 |
Staphylococcus aureus |
PFGE USA100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS681
|
GA-210 |
Staphylococcus aureus |
PFGE USA100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS682
|
GA-256 |
Staphylococcus aureus |
PFGE USA100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS683
|
GA-298 |
Staphylococcus aureus |
PFGE USA300, PVL(+), TSST(-), SCCMEC IV |
|
|
NRS684
|
GA-340 |
Staphylococcus aureus |
PFGE USA300, PVL(+), TSST(-), SCCMEC IV |
|
|
NRS685
|
GA-355 |
Staphylococcus aureus |
PFGE USA500, PVL(-), TSST(-), SCCMEC IV |
|
|
NRS686
|
GA-356 |
Staphylococcus aureus |
PFGE IBERIAN, PVL(-), TSST(-), SCCMEC IV |
|
|
NRS687
|
GA-383 |
Staphylococcus aureus |
PFGE USA300, PVL(+), TSST(-), SCCMEC IV |
|
|
NRS688
|
GA-385 |
Staphylococcus aureus |
PFGE USA300, PVL(+), TSST(-), SCCMEC IV |
|
|
NRS689
|
GA-442 |
Staphylococcus aureus |
PFGE USA700, PVL(-), TSST(-), SCCMEC IV |
|
|
NRS690
|
GA-51 |
Staphylococcus aureus |
PFGE USA100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS691
|
GA-62 |
Staphylococcus aureus |
PFGE USA500, PVL(-), TSST(-), SCCMEC IV |
|
|
NRS692
|
GA-656 |
Staphylococcus aureus |
PFGE USA800, PVL(-), TSST(-), SCCMEC IV |
|
|
NRS693
|
GA-73 |
Staphylococcus aureus |
PFGE USA300, PVL(+), TSST(-), SCCMEC IV |
|
|
NRS694
|
GA-92 |
Staphylococcus aureus |
PFGE USA300, PVL(+), TSST(-), SCCMEC IV |
|
|
NRS695
|
MN-019 |
Staphylococcus aureus |
PFGE USA100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS696
|
MN-026 |
Staphylococcus aureus |
PFGE USA100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS697
|
MN-030 |
Staphylococcus aureus |
PFGE USA100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS698
|
MN-040 |
Staphylococcus aureus |
PFGE USA100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS699
|
MN-052 |
Staphylococcus aureus |
PFGE USA100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS700
|
MN-079 |
Staphylococcus aureus |
PFGE USA100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS701
|
MN-082 |
Staphylococcus aureus |
PFGE USA200, PVL(-), TSST(+), SCCMEC II |
|
|
NRS702
|
MN-094 |
Staphylococcus aureus |
PFGE USA300, PVL(+), TSST(-), SCCMEC IV |
|
|
NRS703
|
MN-095 |
Staphylococcus aureus |
PFGE USA300, PVL(+), TSST(-), SCCMEC IV |
|
|
NRS704
|
MN-113 |
Staphylococcus aureus |
PFGE USA100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS705
|
NY-12 |
Staphylococcus aureus |
PFGE USA100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS706
|
NY-141 |
Staphylococcus aureus |
PFGE USA100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS707
|
NY-155 |
Staphylococcus aureus |
PFGE USA300, PVL(+), TSST(-), SCCMEC IV |
|
|
NRS708
|
NY-177 |
Staphylococcus aureus |
PFGE USA500, PVL(-), TSST(-), SCCMEC IV |
|
|
NRS709
|
NY-208 |
Staphylococcus aureus |
PFGE USA100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS710
|
NY-216 |
Staphylococcus aureus |
PFGE USA100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS711
|
NY-245 |
Staphylococcus aureus |
PFGE USA100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS712
|
NY-276 |
Staphylococcus aureus |
PFGE USA100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS713
|
NY-282 |
Staphylococcus aureus |
PFGE USA100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS714
|
NY-313 |
Staphylococcus aureus |
PFGE USA800, PVL(-), TSST(-), SCCMEC IV |
|
|
NRS715
|
NY-315 |
Staphylococcus aureus |
PFGE USA600, PVL(-), TSST(-), SCCMEC II |
|
|
NRS716
|
NY-336 |
Staphylococcus aureus |
PFGE USA300, PVL(+), TSST(-), SCCMEC IV |
|
|
NRS717
|
NY-51 |
Staphylococcus aureus |
PFGE USA 100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS718
|
NY-54 |
Staphylococcus aureus |
PFGE USA 100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS719
|
NY-76 |
Staphylococcus aureus |
PFGE USA 100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS720
|
OR-10 |
Staphylococcus aureus |
PFGE USA 100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS721
|
OR-130 |
Staphylococcus aureus |
PFGE USA 100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS722
|
OR-131 |
Staphylococcus aureus |
PFGE USA 200, PVL(-), TSST(-), SCCMEC II |
|
|
NRS723
|
OR-172 |
Staphylococcus aureus |
PFGE USA 100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS724
|
OR-229 |
Staphylococcus aureus |
PFGE USA 300, PVL(+), TSST(-), SCCMEC IV |
|
|
NRS725
|
OR-25 |
Staphylococcus aureus |
PFGE USA 300, PVL(+), TSST(-), SCCMEC IV |
|
|
NRS726
|
OR-274 |
Staphylococcus aureus |
PFGE USA 300, PVL(+), TSST(-), SCCMEC IV |
|
|
NRS727
|
OR-283 |
Staphylococcus aureus |
PFGE USA 100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS728
|
OR-293 |
Staphylococcus aureus |
PFGE USA 100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS729
|
OR-297 |
Staphylococcus aureus |
PFGE USA 300, PVL(+), TSST(-), SCCMEC IV |
|
|
NRS730
|
OR-327 |
Staphylococcus aureus |
PFGE USA 1000, PVL(-), TSST(-), SCCMEC IV |
|
|
NRS731
|
OR-54 |
Staphylococcus aureus |
PFGE USA 300, PVL(+), TSST(-), SCCMEC IV |
|
|
NRS732
|
TN-112 |
Staphylococcus aureus |
PFGE USA 300, PVL(+), TSST(-), SCCMEC IV |
|
|
NRS733
|
TN-113 |
Staphylococcus aureus |
PFGE USA 300, PVL(+), TSST(-), SCCMEC IV |
|
|
NRS734
|
TN-116 |
Staphylococcus aureus |
PFGE USA 800, PVL(-), TSST(-), SCCMEC IV |
|
|
NRS735
|
TN-124 |
Staphylococcus aureus |
PFGE USA 100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS736
|
TN-151 |
Staphylococcus aureus |
PFGE USA 300, PVL(+), TSST(-), SCCMEC IV |
|
|
NRS737
|
TN-65 |
Staphylococcus aureus |
PFGE USA 100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS738
|
TN-67 |
Staphylococcus aureus |
PFGE USA 100, PVL(-), TSST(-), SCCMEC II |
|
|
NRS739
|
TN-74 |
Staphylococcus aureus |
PFGE USA300, PVL (+), TSST (-), SCCMEC IV |
|
|
NRS740
|
TN-82 |
Staphylococcus aureus |
PFGE USA200, PVL(-), TSST(+), SCCMec II |
|
|
NRS741
|
TN-90 |
Staphylococcus aureus |
PFGE USA100, PVL(-), TSST(-), SCCMec II |
|
|
NRS745
|
CA-629 |
Staphylococcus aureus |
PFType USA 1000, PVL (-), TSST (-), SCCmec V |
|
|
|
Known Clinically Associated Strains - Others |
|
|
NRS22
|
HIP07930; USA600;99758 |
Staphylococcus aureus |
Healthcare-related MRSA |
|
|
NRS123
|
MW2;C1999000459;USA400;99065 |
Staphylococcus aureus |
A multiply-susceptible, community-acquired MRSA known to carry the Panton-Valentine leukocidin genes and additional virulence genes distinct from hospital-acquired MRSA strains. |
|
|
NRS164
|
A890259 |
Staphylococcus aureus |
Associated with exfoliative toxin-mediated disease (generalized exfoliative syndrome) |
|
|
NRS165
|
A940441 |
Staphylococcus aureus |
Associated with exfoliative toxin-mediated disease (generalized exfoliative syndrome) |
|
|
NRS166
|
A910669 |
Staphylococcus aureus |
Associated with exfoliative toxin-mediated disease (bullous impetigo) |
|
|
NRS167
|
A970675 |
Staphylococcus aureus |
Associated with exfoliative toxin-mediated disease (bullous impetigo) |
|
|
NRS168
|
A850375 |
Staphylococcus aureus |
Associated with enterotoxin-mediated disease (TSS) |
|
|
NRS169
|
A920222 |
Staphylococcus aureus |
Associated with enterotoxin-mediated disease (TSS) |
|
|
NRS170
|
A960562 |
Staphylococcus aureus |
Associated with enterotoxin-mediated disease (TSS) |
|
|
NRS171
|
A970704 |
Staphylococcus aureus |
Associated with enterotoxin-mediated disease (TSS) |
|
|
NRS172
|
A970230 |
Staphylococcus aureus |
Associated with enterotoxin-mediated disease (scarlet fever) |
|
|
NRS173
|
A970656 |
Staphylococcus aureus |
Associated with enterotoxin-mediated disease (scarlet fever) |
|
|
NRS174
|
A900507 |
Staphylococcus aureus |
Associated with TSST-1-mediated disease (nonmenstrual TSS) |
|
|
NRS175
|
A910565 |
Staphylococcus aureus |
Associated with TSST-1-mediated disease (nonmenstrual TSS) |
|
|
NRS176
|
A950211 |
Staphylococcus aureus |
Associated with TSST-1-mediated disease (nonmenstrual TSS) |
|
|
NRS177
|
A960197 |
Staphylococcus aureus |
Associated with TSST-1-mediated disease (nonmenstrual TSS) |
|
|
NRS178
|
A910469 |
Staphylococcus aureus |
Associated with TSST-1-mediated disease (scarlet fever) |
|
|
NRS179
|
A950319 |
Staphylococcus aureus |
Associated with TSST-1-mediated disease (scarlet fever) |
|
|
NRS180
|
A960254 |
Staphylococcus aureus |
Associated with TSST-1-mediated disease (scarlet fever) |
|
|
NRS181
|
A930472 |
Staphylococcus aureus |
Associated with suppurative infections (endocarditis) |
|
|
NRS182
|
A950085 |
Staphylococcus aureus |
Associated with suppurative infections (endocarditis) |
|
|
NRS183
|
A980101 |
Staphylococcus aureus |
Associated with suppurative infections (endocarditis) |
|
|
NRS184
|
A870192 |
Staphylococcus aureus |
Associated with suppurative infections (cellulitis and/or myositis) |
|
|
NRS185
|
A890511 |
Staphylococcus aureus |
Associated with suppurative infections (cellulitis and/or myositis) |
|
|
NRS186
|
A900476 |
Staphylococcus aureus |
Associated with suppurative infections (cellulitis and/or myositis) |
|
|
NRS187
|
A860325 |
Staphylococcus aureus |
Associated with suppurative infections (osteitis and/or osteomyelitis) |
|
|
NRS188
|
A950206 |
Staphylococcus aureus |
Associated with suppurative infections (osteitis and/or osteomyelitis) |
|
|
NRS189
|
A910371 |
Staphylococcus aureus |
Associated with suppurative infections (arthritis) |
|
|
NRS190
|
A970627 |
Staphylococcus aureus |
Associated with suppurative infections (arthritis) |
|
|
NRS191
|
A970698 |
Staphylococcus aureus |
Associated with suppurative infections (arthritis) |
|
|
NRS192
|
C1998000370 |
Staphylococcus aureus |
Community-acquired MRSA, carrying gene for Panton-Valentine leukocidin; was associated with septic arthritis, sepsis, and pneumonia/empyema. |
|
|
NRS193
|
C1999000193 |
Staphylococcus aureus |
Community-acquired MRSA, carrying gene for Panton-Valentine leukocidin; was associated with necrotizing pneumonia and severe sepsis. |
|
|
NRS194
|
C1999000529 |
Staphylococcus aureus |
Community-acquired MRSA, carrying gene for Panton-Valentine leukocidin; was associated with necrotizing pneumonia and severe sepsis. |
|
|
NRS226
|
HT 20020028 |
Staphylococcus aureus |
Associated with myositis |
|
|
NRS227
|
HT 20020030 |
Staphylococcus aureus |
Associated with hip arthritis with toxic shock syndrome |
|
|
NRS228
|
HT 20020037 |
Staphylococcus aureus |
Associated with osteomyelitis |
|
|
NRS229
|
HT 20020044 |
Staphylococcus aureus |
Associated with necrotising pneumonia |
|
|
NRS230
|
HT 20020057 |
Staphylococcus aureus |
Associated with elbow arthritis with scarlet fever |
|
|
NRS231
|
HT 20020058 |
Staphylococcus aureus |
Associated with knee arthritis |
|
|
NRS232
|
HT 20020065 |
Staphylococcus aureus |
Associated with necrotising pneumonia |
|
|
NRS233
|
HT 20020067 |
Staphylococcus aureus |
Associated with bulbous impetigo |
|
|
NRS234
|
HT 20020073 |
Staphylococcus aureus |
Associated with native valve endocarditis |
|
|
NRS235
|
HT 20020075 |
Staphylococcus aureus |
Associated with native valve endocarditis |
|
|
NRS236
|
HT 20020141 |
Staphylococcus aureus |
Associated with bacteremia |
|
|
NRS237
|
HT 20020167 |
Staphylococcus aureus |
Associated with necrotising pneumonia |
|
|
NRS238
|
HT 20020180 |
Staphylococcus aureus |
Associated with impetigo |
|
|
NRS239
|
HT 20020204 |
Staphylococcus aureus |
Associated with generalized exfoliative syndrome |
|
|
NRS240
|
HT 20020229 |
Staphylococcus aureus |
Associated with osteitis |
|
|
NRS241
|
HT 20020233 |
Staphylococcus aureus |
Associated with scarlet fever after varicella |
|
|
NRS242
|
HT 20020238 |
Staphylococcus aureus |
Associated with impetigo |
|
|
NRS243
|
HT 20020252 |
Staphylococcus aureus |
Associated with pneumonia |
|
|
NRS244
|
HT 20020261 |
Staphylococcus aureus |
Associated with spondilodiscitis |
|
|
NRS245
|
HT 20020320 |
Staphylococcus aureus |
Associated with impetigo |
|
|
NRS246
|
HT 20020330 |
Staphylococcus aureus |
Associated with node abscess |
|
|
NRS247
|
HT 20020331 |
Staphylococcus aureus |
Associated with cutaneous abscess |
|
|
NRS248
|
HT 20020338 |
Staphylococcus aureus |
Associated with necrotising pneumonia |
|
|
NRS249
|
HT 20020341 |
Staphylococcus aureus |
Associated with native valve endocarditis |
|
|
NRS250
|
HT 20020344 |
Staphylococcus aureus |
Associated with bulbous impetigo |
|
|
NRS251
|
HT 20020345 |
Staphylococcus aureus |
Associated with cutaneous abscess with toxic shock syndrome |
|
|
NRS252
|
HT 20020351 |
Staphylococcus aureus |
Associated with toxic shock syndrome after burn |
|
|
NRS253
|
HT 20020354 |
Staphylococcus aureus |
Associated with bacteremia |
|
|
NRS254
|
HT 20020365 |
Staphylococcus aureus |
Associated with impetigo with scarlet fever |
|
|
NRS255
|
HT 20020371 |
Staphylococcus aureus |
Associated with furunculosis |
|
|
NRS256
|
HT 20020372 |
Staphylococcus aureus |
Associated bulbous impetigo after varicella |
|
|
NRS257
|
HT 20020375 |
Staphylococcus aureus |
Associated with bacteremia with toxic shock syndrome |
|
|
NRS258
|
HT 20020376 |
Staphylococcus aureus |
Associated with bulbous impetigo |
|
|
NRS259
|
HT 20020381 |
Staphylococcus aureus |
Associated with bulbous impetigo |
|
|
NRS260
|
HT 20020390 |
Staphylococcus aureus |
Associated with skin abscess and Kawasaki syndrome |
|
|
NRS261
|
HT 20020396 |
Staphylococcus aureus |
Associated with recurrent necrotising pneumonia |
|
|
NRS262
|
HT 20020420 |
Staphylococcus aureus |
Associated with necrotising pneumonia |
|
|
NRS263
|
HT 20020436 |
Staphylococcus aureus |
Associated with osteomyelitis |
|
|
NRS264
|
HT 20020438 |
Staphylococcus aureus |
Associated with bacteremia with multiple abscess |
|
|
NRS265
|
HT 20020444 |
Staphylococcus aureus |
Associated with bulbous impetigo |
|
|
NRS266
|
HT 20020455 |
Staphylococcus aureus |
Associated with generalized exfoliative syndrome |
|
|
NRS267
|
HT 20020470 |
Staphylococcus aureus |
Associated with impetigo with scarlet fever |
|
|
NRS382
|
USA100; 626 |
Staphylococcus aureus |
Predominate U.S. hospital associated PFT, also known as the New York/Japan clone.
|
|
|
NRS383
|
USA200; 96758 |
Staphylococcus aureus |
Second most common U.S. health care-associated PFT; EMRSA16 clone |
|
|
NRS384
|
USA300-0114 |
Staphylococcus aureus |
Community-associated. Strain is associated with outbreaks from correctional facilities in MS, GA, TN, TX, and CA, athletic teams in PA, CA, and MSM (CA). |
|
|
NRS385
|
USA500; 95938 |
Staphylococcus aureus |
Healthcare-related MRSA |
|
|
NRS386
|
USA700; 1078 |
Staphylococcus aureus |
Strain is associated with both community and healthcare infections. |
|
|
NRS387
|
USA800; 1045 |
Staphylococcus aureus |
Also known as the Pediatric clone |
|
|
NRS482
|
FPR 3757; USA 300 |
Staphylococcus aureus |
USA 300, Whole Genome Sequence |
|
|
NRS483
|
USA 1000; AIS 2006061 |
Staphylococcus aureus |
USA 1000 |
|
|
NRS484
|
USA 1100; HIP 12899 |
Staphylococcus aureus |
USA 1100 |
|
|
|
Molecular Typing Control Strains |
|
|
NRS22
|
HIP07930; USA600;99758 |
Staphylococcus aureus |
|
|
|
NRS123
|
MW2;C1999000459;USA400;99065 |
Staphylococcus aureus |
|
|
|
NRS382
|
USA100; 626 |
Staphylococcus aureus |
|
|
|
NRS383
|
USA200; 96758 |
Staphylococcus aureus |
|
|
|
NRS384
|
USA300-0114 |
Staphylococcus aureus |
|
|
|
NRS385
|
USA500; 95938 |
Staphylococcus aureus |
|
|
|
NRS386
|
USA700; 1078 |
Staphylococcus aureus |
|
|
|
NRS387
|
USA800; 1045 |
Staphylococcus aureus |
|
|
|
NRS483
|
USA 1000; AIS 2006061 |
Staphylococcus aureus |
|
|
|
NRS484
|
USA 1100; HIP 12899 |
Staphylococcus aureus |
|
|
|
|
Research Strains |
|
|
NRS77
|
NCTC 8325; RN1 |
Staphylococcus aureus |
Standard lab strain; propagating strain for typing phage 47; virulence factor staphylokinase. |
|
|
NRS133
|
NCTC8325 (RN0025) |
Staphylococcus aureus |
RN0001, UV cured of Φ11 and Φ12. all NCTC 8325 derivatives are agr group I. |
|
|
NRS134
|
NCTC8325 (RN0027) |
Staphylococcus aureus |
RN0025, lysogenized with 80α |
|
|
NRS135
|
NCTC8325 (RN0450) |
Staphylococcus aureus |
RN0001 UV cured of Φ11, Φ12, and Φ13; partially agr-defective |
|
|
NRS136
|
NCTC8325 (RN0451) |
Staphylococcus aureus |
RN0450 re-lysogenized with Φ11 |
|
|
NRS137
|
NCTC8325 (RN0453) |
Staphylococcus aureus |
standard donor of Tn551 from pI258 mutant thermosensitive for replication |
|
|
NRS138
|
RN0833 |
Staphylococcus warneri |
Naturally occurring producer of the agrD autoinducing peptide, YINCTNFF, which is an agr inhibitor for all four agr groups in S. aureus. |
|
|
NRS139
|
NCTC8325 (RN0981) |
Staphylococcus aureus |
Heavily mutagenized derivative of RN450 with multiple defects. |
|
|
NRS140
|
NCTC8325 (RN1389) |
Staphylococcus aureus |
Tn554 is a site-specific, high frequency transposon encoding erythromycin and spectinomycin resistances. |
|
|
NRS141
|
NCTC8325 (RN3214) |
Staphylococcus aureus |
pUB110 is a naturally-occuring Skb rolling circle plasmid encoding resistances to aminoglycosides (neomycin & kanamycin) and to bleomycin. It belongs to the pc194 family. It replicates more efficiently in Bacillus subtilis than in S. aureus. |
|
|
NRS142
|
NCTC8325 (RN3763) |
Staphylococcus aureus |
pSA0341 has a repC mutation causing thermosensitive plasmid replication, isolated by S.Iordanesco. |
|
|
NRS143
|
NCTC8325 (RN3984) |
Staphylococcus aureus |
SaPI2 is a phase-related pathogenicity island ~10kb; transduction at high frequency by phage 80. |
|
|
NRS144
|
NCTC8325 (RN4220) |
Staphylococcus aureus |
RN4220 was selected for transformability with DNA from E. coli. It has a partial agr defect. |
|
|
NRS145
|
RN4282 |
Staphylococcus aureus |
SaPI1 is a mobile 15-kb pathogenicity island transduced at high frequency by phage 80α. RN4282 is the strain from which tst was first cloned. |
|
|
NRS146
|
NCTC8325 (RN5843) |
Staphylococcus aureus |
pRN6441 is a derivative of pE194, a 3.8 kb rolling circle plasmid, with a mutation in repF causing thermosesitive replication, plus the insertion of the puC19 multiple cloning site in its single PstI site. |
|
|
NRS147
|
NCTC8325 (RN6390B) |
Staphylococcus aureus |
RN6390 is the strain from which the agr locus was first cloned. It is the agr group I prototype. RN6390 frequently gives rise to agr-negative mutants. RN6390B is an agr-positive re-isolate from an RN6390 stock culture that had become mostly agr-negative. |
|
|
NRS148
|
RN6432 ;"Smith diffuse" |
Staphylococcus aureus |
Heavily encapsulated; undergoes phase variation to generate capsule-variants that form compact colonies in serum 0.3% agar and is known as "Smith compact". |
|
|
NRS149
|
502A (RN6607) |
Staphylococcus aureus |
standard agr group II prototype; formerly used for bioprotection against 80/81 epidemic phage type. |
|
|
NRS150
|
NCTC8325 (RN6709) |
Staphylococcus aureus |
pRN5543 is a derivative of pC194 with the pUC19 multiple cloning site at the HindIII site, one HindIII site eliminated. |
|
|
NRS151
|
NCTC8325 (RN6911) |
Staphylococcus aureus |
agr locus in 8325-4 replaced by tetM; overproduces protein A. |
|
|
NRS152
|
WGB4316 (RN7044) |
Staphylococcus aureus |
pWBG32 is a small rolling circle of the pSN2 family encoding an efflux pump for quarternary amines. |
|
|
NRS153
|
RN8540 |
Staphylococcus aureus |
agr group IV prototype |
|
|
NRS154
|
RN4850 (RN9121) |
Staphylococcus aureus |
agr-null derivative of agr group IV prototype |
|
|
NRS155
|
502A (RN9120) |
Staphylococcus aureus |
agr-null derivative of 502A, agr-group II prototype. |
|
|
NRS281
|
COLVA |
Staphylococcus aureus |
Vancomycin-resistant transconjugant |
|
|
NRS407
|
HIP12467 |
Enterococcus faecalis |
co-isolate of Michigan VRSA (VRS1) |
|
|
NRS408
|
HIP11713 |
Staphylococcus aureus |
Probable recipient of Tn1546 from Enterococcus faecalis to produce VRSA (VRS1) |
|
|
|
Vector Collection (E. Charpentier/ Dr. Novick @ NYU) |
|
| |
|
|
|
|
|
|
NRS542
|
RN9542 |
E. coli DH5α |
pCN1 |
|
|
|
NRS543
|
RN9543 |
E. coli DH5α |
pCN2 |
|
|
|
NRS544
|
RN9544 |
E. coli DH5α |
pCN3 |
|
|
|
NRS545
|
RN9545 |
S. aureus RN4220 |
pCN3 |
|
|
|
NRS546
|
RN9546 |
E.coli. DH5α |
pCN4 |
|
|
|
NRS547
|
RN9547 |
S. aureus RN4220 |
pCN4 |
|
|
|
NRS548
|
RN9549 |
S. aureus RN4220 |
pCN5 |
|
|
|
NRS549
|
RN9551 |
S. aureus RN4220 |
pCN6 |
|
|
|
NRS550
|
RN9553 |
S. aureus RN4220 |
pCN7 |
|
|
|
NRS551
|
RN9555 |
S. aureus RN4220 |
pCN8 |
|
|
|
NRS552
|
RN9557 |
S. aureus RN4220 |
pCN11 |
|
|
|
NRS553
|
RN9556 |
S. aureus RN4220 |
pCN10 |
|
|
|
NRS554
|
RN9558 |
E. coli DH5α |
pCN12 |
|
|
|
NRS555
|
RN9548 |
E. coli DH5α |
pCN5 |
|
|
|
NRS556
|
RN9550 |
|
pCN6 |
|
|
|
NRS557
|
RN9552 |
E. coli DH5α |
pCN7 |
|
|
|
NRS558
|
RN9554 |
E. coli DH5α |
pCN8 |
|
|
|
NRS560
|
RN9560 |
E. coli DH5α |
pCN13 |
|
|
|
NRS561
|
RN9561 |
S. aureus RN4220 |
pCN13 |
|
|
|
NRS562
|
RN9561 |
E. coli DH5α |
pCN14 |
|
|
|
NRS563
|
RN9563 |
S. aureus RN4220 |
pCN14 |
|
|
|
NRS564
|
RN9564 |
E. coli DH5α |
pCN15 |
|
|
|
NRS566
|
RN9566 |
E. coli DH5α |
pCN16 |
|
|
|
NRS567
|
RN9567 |
S. aureus RN4220 |
pCN16 |
|
|
|
NRS568
|
RN9568 |
E. coli DH5α |
pCN17 |
|
|
|
NRS569
|
RN9569 |
S. aureus RN4220 |
pCN17 |
|
|
|
NRS570
|
RN9570 |
S. aureus RN4220 |
pCN18 |
|
|
|
NRS571
|
RN9571 |
S. aureus RN4220 |
pCN19 |
|
|
|
NRS572
|
RN9572 |
S. aureus RN4220 |
pCN20 |
|
|
|
NRS573
|
RN9573 |
E. coli DH5α |
pCN21 |
|
|
|
NRS574
|
RN9574 |
S. aureus RN4220 |
pCN21 |
|
|
|
NRS575
|
RN9575 |
S. aureus RN4220 |
pCN23 |
|
|
|
NRS576
|
RN9576 |
S. aureus RN4220 |
pCN26 |
|
|
|
NRS577
|
RN9577 |
E. coli DH5α |
pCN29 |
|
|
|
NRS578
|
RN9578 |
E. coli DH5α |
pCN30 |
|
|
|
NRS579
|
RN9579 |
E. coli DH5α |
pCN31 |
|
|
|
NRS580
|
RN9580 |
E. coli DH5α |
pCN32 |
|
|
|
NRS581
|
RN9581 |
E. coli DH5α |
pCN33 |
|
|
|
NRS582
|
RN9582 |
S. aureus RN4220 |
pCN33 |
|
|
|
NRS583
|
RN9583 |
E. coli DH5α |
pCN34 |
|
|
|
NRS585
|
RN9585 |
E. coli DH5α |
pCN35 |
|
|
|
NRS586
|
RN9586 |
S. aureus RN4220 |
pCN35 |
|
|
|
NRS587
|
RN9587 |
E. coli DH5α |
pCN36 |
|
|
|
NRS588
|
RN9588 |
S. aureus RN4220 |
pCN36 |
|
|
|
NRS589
|
RN9589 |
E. coli DH5α |
pCN37 |
|
|
|
NRS590
|
RN9590 |
S. aureus RN4220 |
pCN37 |
|
|
|
NRS591
|
RN9591 |
S. aureus RN4220 |
pCN38 |
|
|
|
NRS592
|
RN9592 |
E. coli DH5α |
pCN39 |
|
|
|
NRS593
|
RN9593 |
S. aureus RN4220 |
pCN39 |
|
|
|
NRS594
|
RN9594 |
S. aureus RN4220 |
pCN40 |
|
|
|
NRS595
|
RN9595 |
E. coli DH5α |
pCN41 |
|
|
|
NRS596
|
RN9596 |
S. aureus RN4220 |
pCN41 |
|
|
|
NRS597
|
RN9597 |
E. coli DH5α |
pCN42 |
|
|
|
NRS598
|
RN9598 |
S. aureus RN4220 |
pCN42 |
|
|
|
NRS600
|
RN9600 |
E. coli DH5α |
pCN44 |
|
|
|
NRS601
|
RN9601 |
S. aureus RN4220 |
pCN44 |
|
|
|
NRS602
|
RN9602 |
E. coli DH5α |
pCN45 |
|
|
|
NRS603
|
RN9603 |
S. aureus RN4220 |
pCN45 |
|
|
|
NRS604
|
RN9604 |
E. coli DH5α |
pCN46 |
|
|
|
NRS605
|
RN9605 |
E. coli DH5α |
pCN47 |
|
|
|
NRS606
|
RN9606 |
S. aureus RN4220 |
pCN47 |
|
|
|
NRS607
|
RN9607 |
E. coli DH5α |
pCN48 |
|
|
|
NRS608
|
RN9608 |
S. aureus RN4220 |
pCN48 |
|
|
|
NRS609
|
RN9609 |
E. coli DH5α |
pCN49 |
|
|
|
NRS610
|
RN9610 |
S. aureus RN4220 |
pCN49 |
|
|
|
NRS611
|
RN9611 |
E. coli DH5α |
pCN50 |
|
|
|
NRS612
|
RN9612 |
S. aureus RN4220 |
pCN50 |
|
|
|
NRS613
|
RN9613 |
E. coli DH5α |
pCN51 |
|
|
|
NRS615
|
RN9615 |
E. coli DH5α |
pCN52 |
|
|
|
NRS616
|
RN9616 |
S. aureus RN4220 |
pCN52 |
|
|
|
NRS617
|
RN9617 |
E. coli DH5α |
pCN53 |
|
|
|
NRS618
|
RN9618 |
S. aureus RN4220 |
pCN53 |
|
|
|
NRS619
|
RN9619 |
E. coli DH5α |
pCN54 |
|
|
|
NRS620
|
RN9620 |
S. aureus RN4220 |
pCN54 |
|
|
|
NRS621
|
RN9621 |
E. coli DH5α |
pCN56 |
|
|
|
NRS622
|
RN9622 |
S. aureus RN4220 |
pCN56 |
|
|
|
NRS623
|
RN9623 |
S. aureus RN4220 |
pCN57 |
|
|
|
NRS624
|
RN9668 |
E. coli DH5α |
pCN58 |
|
|
|
NRS625
|
RN9669 |
S. aureus RN4220 |
pCN58 |
|
|
|
NRS626
|
RN9670 |
E. coli DH5α |
pCN59 |
|
|
|
NRS627
|
RN9671 |
S. aureus RN4220 |
pCN59 |
|
|
|
NRS628
|
RN9870 |
S. aureus RN4220 |
pCN55 |
rsbU- |
|
|
NRS631
|
RN9879 |
S. aureus RN0001 |
pCN57 |
rsbU- |
|
|
NRS632
|
RN9880 |
E. coli DH5α |
pCN55 |
|
|
|
NRS633
|
RN9881 |
S. aureus RN4220 |
pCN55 |
rsbU- |
|
|
NRS634
|
RN9882 |
S. aureus RN4220 |
pCN68 |
rsbU- |
|
|
NRS635
|
RN10014 |
S. aureus RN6734 |
pCN50 |
has::intron |
|
|
NRS636
|
RN10021 |
S. aureus RN7206 |
pCN50 |
Δagr::tetM has::intron |
|
|
|
* MGE stands for Mobile Genetic Element
|
|
1. This is not a complete list of chomosomal markers.
|
|
Virulent and Toxin Producing Strains |
|
|
NRS101
|
RP62A; ATCC 35984 |
Staphylococcus epidermidis |
Prototype biofilm producer strain, researched by Dr. Gerald Pier of the Brigham and Women's Hospital. |
|
|
NRS102
|
Reynolds |
Staphylococcus aureus |
Produces capsular polysaccharide type 5 |
|
|
NRS103
|
Becker |
Staphylococcus aureus |
Produces capsular polysaccharide type 8 |
|
|
NRS104
|
Cowan I; ATCC12598;NCTC8530 |
Staphylococcus aureus |
Over-expression of protein A |
|
|
NRS105
|
Wood 46 |
Staphylococcus aureus |
Protein A-deficient strain |
|
|
NRS109
|
FRI361 |
Staphylococcus aureus |
SEC2 |
|
|
NRS110
|
FRI472 |
Staphylococcus aureus |
D & J on plamid |
|
|
NRS111
|
FRI913 |
Staphylococcus aureus |
SEA, SEC3, SEE, TSST-1 |
|
|
NRS112
|
MN8 |
Staphylococcus aureus |
TSST-1 |
|
|
NRS113
|
MNDON |
Staphylococcus aureus |
SEC1, SEG, SEH, SEI |
|
|
NRS114
|
MNHOCH |
Staphylococcus aureus |
SEB |
|
|
NRS156
|
A900322 |
Staphylococcus aureus |
egc, a highly prevalent operon of enterotoxin gene, which forms a putative nursery of superantigens in S. aureus. |
|
|
NRS157
|
A980592 |
Staphylococcus aureus |
Association between positive gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. |
|
|
NRS158
|
HT 2000 0319 |
Staphylococcus aureus |
Strain was isolated from skin infection, carrying gene for Panton-Valentine leukocidin. |
|
|
NRS161
|
HT 2000 0509 |
Staphylococcus aureus |
Strain was isolated from skin infection, carrying gene for Panton-Valentine leukocidin. |
|
|
NRS162
|
HT 2000 0328 |
Staphylococcus aureus |
Strain was isolated from skin infection, carrying gene for Panton-Valentine leukocidin. |
|
|
|
|
|